Dong Xue

1.8k total citations
74 papers, 1.2k citations indexed

About

Dong Xue is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Dong Xue has authored 74 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 21 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Dong Xue's work include Circular RNAs in diseases (11 papers), MicroRNA in disease regulation (10 papers) and Cancer-related molecular mechanisms research (10 papers). Dong Xue is often cited by papers focused on Circular RNAs in diseases (11 papers), MicroRNA in disease regulation (10 papers) and Cancer-related molecular mechanisms research (10 papers). Dong Xue collaborates with scholars based in China, United Kingdom and United States. Dong Xue's co-authors include Xiaozhou He, Cuixing Zhou, Yimeng Chen, Renfang Xu, Qianfeng Zhuang, Shaohua Wang, Jie Sun, Rongrong Cai, Rong Huang and Sai Tian and has published in prestigious journals such as Scientific Reports, BioMed Research International and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

Dong Xue

69 papers receiving 1.2k citations

Peers

Dong Xue

ONCOL

PRM

IMMUN

Laura Necula Romania

Nicolas Pottier France

Simona Mihai Romania

Leon Bernal‐Mizrachi United States

Miklós Garami Hungary

Vasileios Ragos Greece

Jie Huang China

Christelle Cauffiez France

Carlo Giansante Italy

Xiaohua Wang China

Laura Necula Romania

Dong Xue

563 ×1.0

333 ×1.0

293 ×1.4

ONCOL

285 ×1.7

PRM

213 ×1.6

IMMUN

Citations per year, relative to Dong Xue Dong Xue (= 1×) peers Laura Necula

Countries citing papers authored by Dong Xue

Since Specialization

Citations

This map shows the geographic impact of Dong Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Xue more than expected).

Fields of papers citing papers by Dong Xue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Xue. The network helps show where Dong Xue may publish in the future.

Co-authorship network of co-authors of Dong Xue

This figure shows the co-authorship network connecting the top 25 collaborators of Dong Xue. A scholar is included among the top collaborators of Dong Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Xue. Dong Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Shuang, Guannan Shu, Minyu Chen, et al.. (2025). STX17-DT facilitates axitinib resistance in renal cell carcinoma by inhibiting mitochondrial ROS accumulation and ferroptosis. Cell Death and Disease. 16(1). 125–125. 4 indexed citations

Xue, Dong, Jianchao Li, Zengwu Wang, et al.. (2025). Effectiveness, safety and adherence of home-based exercise rehabilitation in patients with coronary heart disease patients: A systematic review. Medicine in Novel Technology and Devices. 26. 100361–100361.

Chen, Yimeng, Yichen He, Zhengsheng Li, et al.. (2024). METTL3 facilitates renal cell carcinoma progression by PLOD2 m6A-methylation under prolonged hypoxia. Cell Death and Disease. 15(1). 62–62. 19 indexed citations

Xu, Renfang, et al.. (2024). Don't wait any longer, conceive in time: a systematic review and meta-analysis based on semen parameters after varicocelectomy. International Urology and Nephrology. 56(10). 3217–3229. 2 indexed citations

Liu, Jiaojiao, Yingying Guo, Dong Xue, et al.. (2023). Chimpanzee adenovirus-mediated multiple gene therapy for age-related macular degeneration. iScience. 26(10). 107939–107939. 8 indexed citations

Sun, Yangyang, et al.. (2022). Exosomal miR-4639 and miR-210 in Plasma and Urine as Biomarkers in IgA Nephropathy. The Nephron journals/Nephron journals. 146(6). 539–552. 8 indexed citations

Xue, Dong, et al.. (2021). Apolipoprotein C1 stimulates the malignant process of renal cell carcinoma via the Wnt3a signaling. Cancer Cell International. 21(1). 13 indexed citations

Liang, Bin, Cuixing Zhou, Hao Lu, et al.. (2021). Upregulation of miR-18a-5p promotes the proliferation of prostate cancer via inhibiting the expression of SLC40A1. Pathology - Research and Practice. 224. 153448–153448. 17 indexed citations

Zhuang, Qianfeng, Min Fan, Jie Shen, et al.. (2021). Overexpression of Capns1 Predicts Poor Prognosis and Correlates with Tumor Progression in Renal Cell Carcinoma. Urologia Internationalis. 105(7-8). 697–704. 1 indexed citations

10.

Xue, Dong, et al.. (2021). Cellular Mechanism of Gene Mutations and Potential Therapeutic Targets in Ovarian Cancer. Cancer Management and Research. Volume 13. 3081–3100. 40 indexed citations

11.

Wang, Kai, Zhen Chen, Min Fan, et al.. (2018). Prognostic significance of galectin-1 expression in patients with cancer: a meta-analysis. Cancer Cell International. 18(1). 108–108. 27 indexed citations

12.

Xue, Dong, et al.. (2017). Preventive effect of Aster tataricus on oxidative stress and biomarker of renal function in rat fed with high fat diet and sucrose diet. Biomedical Research-tokyo. 28(4). 1647–1653. 3 indexed citations

13.

Xue, Dong & Yan Wang. (2017). Molecular mechanism of microRNA-93 in suppressing the cell proliferation of cervical cancer by adjusting the EGFR/AKT signal pathway. Biomedical Research-tokyo. 28(11). 4957–4961. 2 indexed citations

14.

Gao, Yi, Lihong Qin, Yuwei Yang, et al.. (2017). PDPN gene promotes the proliferation of immature Bovine Sertoli cells in vitro. Animal Reproduction Science. 179. 35–43. 7 indexed citations

15.

Zhao, Wei, et al.. (2017). Marsdenia tenacissima extract overcomes Axl- and Met-mediated erlotinib and gefitinib cross-resistance in non-small cell lung cancer cells. Oncotarget. 8(34). 56893–56905. 20 indexed citations

16.

Xue, Dong, Xiaozhou He, & Cuixing Zhou. (2014). Serum Hepcidin Level Correlates With Hyperlipidemia Status in Patients Following Allograft Renal Transplantation. Transplantation Proceedings. 46(1). 156–159. 7 indexed citations

17.

Xu, Haiyan, et al.. (2013). Involvement of miR-338-5p in antibody-mediated renal allograft rejection by targeting TRAF3. 34(9). 554–558. 1 indexed citations

18.

Xue, Dong, et al.. (2013). Correlation Between CD14+CD16++ Monocytes in Peripheral Blood and Hypertriglyceridemia After Allograft Renal Transplantation. Transplantation Proceedings. 45(9). 3279–3283. 2 indexed citations

19.

Xue, Dong, Yuning Song, Weiguo Liu, & Guo-Xiu Li. (2009). MMP-9, a Potential Target for Cerebral Ischemic Treatment. Current Neuropharmacology. 7(4). 269–275. 80 indexed citations

20.

Xue, Dong, et al.. (1994). Activity of in vitro anti-influenza virus of arctigenin. Zhongcaoyao. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact